Scienture Holdings (SCNX) closed at $2.77 on October 22, 2026, down 4.6% from the previous close, on volume of 16,652 shares (30-day average 6,281,588).
Data as of October 22, 2026.
Globe Newswire (Thu, 22-Oct 8:05 AM ET)
Scienture Holdings Regains Nasdaq Compliance Amid Revenue Surge
TipRanks (Mon, 19-Oct 4:32 PM ET)
Market Chameleon (Tue, 13-Oct 7:23 AM ET)
Globe Newswire (Tue, 13-Oct 8:05 AM ET)
Globe Newswire (Fri, 2-Oct 8:05 AM ET)
Scienture Holdings, Inc. Announces Reverse Stock Split
Globe Newswire (Wed, 30-Sep 4:05 PM ET)
Globe Newswire (Tue, 22-Sep 8:15 AM ET)
Globe Newswire (Wed, 9-Sep 8:55 AM ET)
Globe Newswire (Fri, 14-Aug 8:08 AM ET)
SCIENTURE’s REZENOPY Launch Expands Access to High-Dose Opioid Overdose Treatment Across the U.S.
Market Chameleon (Wed, 12-Aug 7:58 AM ET)
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
Scienture Holdings trades on the NASDAQ stock market under the symbol SCNX.
As of October 23, 2026, SCNX stock price declined to $2.64 with 10,513 million shares trading.
SCNX has a beta of 3.10, meaning it tends to be more sensitive to market movements. SCNX has a correlation of 0.08 to the broad based SPY ETF.
SCNX has a market cap of $4.34 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that SCNX belongs to (by Net Assets): VXF, VTI.
SCNX has underperformed the market in the last year with a price return of -81.5% while the SPY ETF gained +15.4%. SCNX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -73.6% and -31.6%, respectively, while the SPY returned +2.3% and -1.4%, respectively.
SCNX support price is $2.46 and resistance is $3.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SCNX shares will trade within this expected range on the day.
